There are concerns that the ECB's low interest rates are not feeding through to those economies most in need of a boost, with potential lenders still worried about the economic health of countries such as Greece and Spain.
Some consumer advocates argue that the FDA is too understaffed to investigate all the potential problems in its files, that regulatory actions often take years and that consumers and health-care professionals need better safety information in the meantime.
We believe that giving freedom of action and emancipation of human potential in the country will lead to the social protection of those who need it, to the strengthening of health and a rise in education.